BCL2 and diffuse large B-cell lymphoma: Quesada et al. [13] studied 663 patients with de novo DLBCL and found that 12% of patients had extra MYC copies, 16% of patients had extra BCL2 copies, and 13% of patients had extra BCL6 copies.